Erich Platzer - 18 Jan 2022 Form 4 Insider Report for Aptose Biosciences Inc. (APTOF)

Role
Director
Signature
/s/ Janet Clennett as attorney-in-fact for Erich Platzer
Issuer symbol
APTOF
Transactions as of
18 Jan 2022
Net transactions value
$0
Form type
4
Filing time
20 Jan 2022, 16:11:11 UTC
Previous filing
20 Dec 2021
Next filing
23 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APTO Director Stock Option (Right to Buy) Award $0 +50,000 $0.000000 50,000 18 Jan 2022 Common Shares 50,000 $1.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on January 18, 2022, and vest as follows: 50% vest on January 18, 2023; 25% vest on January 18, 2024; and 25% vest on January 18, 2025.